| SC 13G | 2023-02-08 | STATE STREET CORP | Arcutis Biotherapeutics, Inc. | - | 6.0% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | Arcutis Biotherapeutics, Inc. | 5,214,258 | 8.6% | EDGAR |
| SC 13D/A | 2022-08-26 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 2,828,356 | 4.7% | EDGAR |
| SC 13D/A | 2022-08-09 | Frazier Life Sciences VIII, L.P. | Arcutis Biotherapeutics, Inc. | 8,684,232 | 14.5% | EDGAR |
| SC 13D/A | 2022-08-08 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 3,146,724 | 5.4% | EDGAR |
| SC 13D/A | 2022-08-08 | Bain Capital Life Sciences Fund, L.P. | Arcutis Biotherapeutics, Inc. | 2,721,436 | 4.5% | EDGAR |
| SC 13D/A | 2022-06-28 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 3,534,537 | 6.9% | EDGAR |
| SC 13D/A | 2022-05-27 | Bain Capital Life Sciences Fund, L.P. | Arcutis Biotherapeutics, Inc. | 2,721,436 | 5.3% | EDGAR |
| SC 13D/A | 2022-04-08 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 3,840,564 | 7.6% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Arcutis Biotherapeutics, Inc. | 2,644,177 | 5.3% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Arcutis Biotherapeutics, Inc. | 7,544,212 | 15.0% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Arcutis Biotherapeutics, Inc. | 4,313,864 | 8.6% | EDGAR |
| SC 13G | 2021-12-15 | Point72 Asset Management, L.P. | Arcutis Biotherapeutics, Inc. | 2,534,286 | 5.0% | EDGAR |
| SC 13D/A | 2021-05-12 | Frazier Life Sciences VIII, L.P. | Arcutis Biotherapeutics, Inc. | 8,434,232 | 16.8% | EDGAR |
| SC 13D/A | 2021-02-09 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 4,267,564 | 8.8% | EDGAR |
| SC 13D/A | 2021-02-09 | Frazier Life Sciences VIII, L.P. | Arcutis Biotherapeutics, Inc. | 10,542,790 | 21.7% | EDGAR |
| SC 13D/A | 2021-02-08 | Bain Capital Life Sciences Fund, L.P. | Arcutis Biotherapeutics, Inc. | 3,609,796 | 7.4% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Arcutis Biotherapeutics, Inc. | 6,545,164 | 15.0% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Arcutis Biotherapeutics, Inc. | 2,895,054 | 6.6% | EDGAR |
| SC 13D/A | 2020-10-07 | ORBIMED ADVISORS LLC | Arcutis Biotherapeutics, Inc. | 4,267,564 | 9.9% | EDGAR |